MedTrace Logo

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.

NCT00681850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4027

Last updated 2020-01-22

No results posted yet for this study

Summary

Demonstrate that the use of benchmarking improves quality of patient care, in particular the control of diabetes, lipids and blood pressure, by determining the percentage of patients in the benchmarking group achieving pre-set targets for HbA1c 14,18, LDL-cholesterol16,18 and Systolic Blood Pressure17,18 versus control group (non-benchmarking group) after 12 months of follow-up.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Hermans, M. Prof. · UCL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Belgium
  • Greece
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00681850 on ClinicalTrials.gov